| Identification | Back Directory | [Name]
5,6,12,13-tetrachloro-2,9-bis(2-(dimethylamino)ethyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone | [CAS]
932740-48-2 | [Synonyms]
5,6,12,13-tetrachloro-2,9-bis(2-(dimethylamino)ethyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone | [Molecular Formula]
C32H24Cl4N4O4 | [MOL File]
932740-48-2.mol | [Molecular Weight]
670.37 |
| Chemical Properties | Back Directory | [Boiling point ]
824.459±65.00 °C(Press: 760.00 Torr)(predicted) | [density ]
1.574±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | [solubility ]
Chloroform: Soluble
Methanol: Slightly soluble | [pka]
8.849±0.28(predicted) |
| Hazard Information | Back Directory | [Uses]
PDIC-NN is an intermediate in the synthesis of PDIC-NS. PDIC-NS is a STING activator with anticancer activity[1]. | [References]
[1] Wang S, et al. Inhibition of human and rat placental 3β-hydroxysteroid dehydrogenases by bisphenol A analogues depends on their hydrophobicity: in silico docking analysis[J]. Chemico-Biological Interactions, 2024: 111251. DOI:10.1016/j.cbi.2024.111251
[2] Zhao X, et al. Sulfonated Perylene as Three-in-One STING Agonist for Cancer Chemo-Immunotherapy. Angew Chem Int Ed Engl. 2024 Mar 11;63(11):e202318799. DOI:10.1002/anie.202318799 |
|
|